Lixisenatide as add-on therapy to basal insulin

Many patients with type 2 diabetes mellitus do not achieve target glycosylated hemoglobin A(1c) levels despite optimally titrated basal insulin and satisfactory fasting plasma glucose levels. Current evidence suggests that HbA(1c) levels are dictated by both basal glucose and postprandial glucose le...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Dominique Xavier, Butler, Emma Louise, Evans, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865973/
https://www.ncbi.nlm.nih.gov/pubmed/24363554
http://dx.doi.org/10.2147/DDDT.S45108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865973/
https://www.ncbi.nlm.nih.gov/pubmed/24363554
http://dx.doi.org/10.2147/DDDT.S45108

Ejemplares similares